Interferon alpha-2b (Hanmi)

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameInterferon alpha-2b (Hanmi)
Drug Alias NameHM-10660ALAPS-IFNaLAPS-10660A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionImmunostimulantsInterferon alpha replacements
TargetsInterferon alpha
Therapy Area/IndicationsHepatitis C, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlandsMexico
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHanmi Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsHepatitis C, Chronic

Other Information

ATC CodeL03AB05
Related LinksWikipedia